The present invention is directed to macrocycle derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibitors of .beta.-secretase, also known as .beta.-site cleaving enzyme and BACE, BACE1, Asp2 and memapsin2.